nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrapone—CYP11B2—Hydrocortisone—ulcerative colitis	0.307	0.348	CbGbCtD
Metyrapone—CYP11B1—Hydrocortisone—ulcerative colitis	0.199	0.226	CbGbCtD
Metyrapone—CYP2A6—Nicotine—ulcerative colitis	0.0788	0.0895	CbGbCtD
Metyrapone—CYP2E1—Nicotine—ulcerative colitis	0.052	0.0591	CbGbCtD
Metyrapone—CYP2A6—Prednisolone—ulcerative colitis	0.0519	0.0589	CbGbCtD
Metyrapone—CYP3A4—Budesonide—ulcerative colitis	0.0362	0.0411	CbGbCtD
Metyrapone—CYP2A6—Dexamethasone—ulcerative colitis	0.0306	0.0347	CbGbCtD
Metyrapone—CYP2E1—Dexamethasone—ulcerative colitis	0.0202	0.0229	CbGbCtD
Metyrapone—CYP3A4—Methylprednisolone—ulcerative colitis	0.0162	0.0184	CbGbCtD
Metyrapone—CYP3A4—Nicotine—ulcerative colitis	0.0158	0.0179	CbGbCtD
Metyrapone—CYP3A4—Cholecalciferol—ulcerative colitis	0.0141	0.0161	CbGbCtD
Metyrapone—CYP3A4—Triamcinolone—ulcerative colitis	0.0123	0.0139	CbGbCtD
Metyrapone—CYP3A4—Betamethasone—ulcerative colitis	0.0105	0.0119	CbGbCtD
Metyrapone—CYP3A4—Prednisolone—ulcerative colitis	0.0104	0.0118	CbGbCtD
Metyrapone—CYP3A4—Hydrocortisone—ulcerative colitis	0.00983	0.0112	CbGbCtD
Metyrapone—CYP3A4—Prednisone—ulcerative colitis	0.00979	0.0111	CbGbCtD
Metyrapone—Adrenal insufficiency—Budesonide—ulcerative colitis	0.00839	0.0787	CcSEcCtD
Metyrapone—CYP3A4—Dexamethasone—ulcerative colitis	0.00611	0.00695	CbGbCtD
Metyrapone—ABCC3—bile duct—ulcerative colitis	0.00605	0.72	CbGeAlD
Metyrapone—Niacin—SLC22A5—ulcerative colitis	0.00484	1	CrCbGaD
Metyrapone—Bone marrow depression—Mercaptopurine—ulcerative colitis	0.0039	0.0366	CcSEcCtD
Metyrapone—Adrenal insufficiency—Prednisone—ulcerative colitis	0.00361	0.0338	CcSEcCtD
Metyrapone—Hirsutism—Budesonide—ulcerative colitis	0.00302	0.0284	CcSEcCtD
Metyrapone—Hirsutism—Mesalazine—ulcerative colitis	0.00246	0.0231	CcSEcCtD
Metyrapone—Bone marrow depression—Azathioprine—ulcerative colitis	0.00232	0.0218	CcSEcCtD
Metyrapone—Endocrine disorder—Budesonide—ulcerative colitis	0.00212	0.0199	CcSEcCtD
Metyrapone—Bone marrow depression—Mesalazine—ulcerative colitis	0.00212	0.0199	CcSEcCtD
Metyrapone—Dermatitis atopic—Mesalazine—ulcerative colitis	0.00193	0.0181	CcSEcCtD
Metyrapone—Hirsutism—Prednisolone—ulcerative colitis	0.00179	0.0168	CcSEcCtD
Metyrapone—Hirsutism—Hydrocortisone—ulcerative colitis	0.00175	0.0164	CcSEcCtD
Metyrapone—Hirsutism—Triamcinolone—ulcerative colitis	0.00165	0.0154	CcSEcCtD
Metyrapone—Hirsutism—Methylprednisolone—ulcerative colitis	0.00164	0.0154	CcSEcCtD
Metyrapone—Pancytopenia—Mercaptopurine—ulcerative colitis	0.00157	0.0147	CcSEcCtD
Metyrapone—Abdominal discomfort—Nicotine—ulcerative colitis	0.00153	0.0144	CcSEcCtD
Metyrapone—Hirsutism—Betamethasone—ulcerative colitis	0.00149	0.014	CcSEcCtD
Metyrapone—Hirsutism—Dexamethasone—ulcerative colitis	0.00149	0.014	CcSEcCtD
Metyrapone—Dermatitis atopic—Prednisolone—ulcerative colitis	0.00141	0.0132	CcSEcCtD
Metyrapone—Hirsutism—Prednisone—ulcerative colitis	0.0013	0.0122	CcSEcCtD
Metyrapone—Dermatitis atopic—Triamcinolone—ulcerative colitis	0.00129	0.0121	CcSEcCtD
Metyrapone—Endocrine disorder—Hydrocortisone—ulcerative colitis	0.00123	0.0115	CcSEcCtD
Metyrapone—Alopecia—Mercaptopurine—ulcerative colitis	0.00117	0.011	CcSEcCtD
Metyrapone—Dermatitis atopic—Prednisone—ulcerative colitis	0.00102	0.00958	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—ulcerative colitis	0.000973	0.00913	CcSEcCtD
Metyrapone—Hypertension—Nicotine—ulcerative colitis	0.000963	0.00903	CcSEcCtD
Metyrapone—Abdominal discomfort—Azathioprine—ulcerative colitis	0.000944	0.00885	CcSEcCtD
Metyrapone—Pancytopenia—Azathioprine—ulcerative colitis	0.000935	0.00877	CcSEcCtD
Metyrapone—Skin disorder—Mercaptopurine—ulcerative colitis	0.000913	0.00856	CcSEcCtD
Metyrapone—Endocrine disorder—Prednisone—ulcerative colitis	0.000912	0.00856	CcSEcCtD
Metyrapone—Nervous system disorder—Nicotine—ulcerative colitis	0.000893	0.00837	CcSEcCtD
Metyrapone—Abdominal discomfort—Mesalazine—ulcerative colitis	0.00086	0.00806	CcSEcCtD
Metyrapone—Pancytopenia—Mesalazine—ulcerative colitis	0.000851	0.00799	CcSEcCtD
Metyrapone—Hypotension—Nicotine—ulcerative colitis	0.000851	0.00798	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Mercaptopurine—ulcerative colitis	0.000811	0.00761	CcSEcCtD
Metyrapone—Angiopathy—Budesonide—ulcerative colitis	0.000801	0.00751	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Nicotine—ulcerative colitis	0.000786	0.00737	CcSEcCtD
Metyrapone—Alopecia—Budesonide—ulcerative colitis	0.00078	0.00732	CcSEcCtD
Metyrapone—Pain—Nicotine—ulcerative colitis	0.000778	0.0073	CcSEcCtD
Metyrapone—Gastrointestinal pain—Nicotine—ulcerative colitis	0.000744	0.00698	CcSEcCtD
Metyrapone—Abdominal pain—Nicotine—ulcerative colitis	0.00072	0.00675	CcSEcCtD
Metyrapone—Alopecia—Azathioprine—ulcerative colitis	0.000696	0.00653	CcSEcCtD
Metyrapone—Hypertension—Budesonide—ulcerative colitis	0.000663	0.00622	CcSEcCtD
Metyrapone—Angiopathy—Mesalazine—ulcerative colitis	0.000651	0.00611	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.000649	0.00609	CcSEcCtD
Metyrapone—Alopecia—Mesalazine—ulcerative colitis	0.000634	0.00595	CcSEcCtD
Metyrapone—Nervous system disorder—Budesonide—ulcerative colitis	0.000615	0.00577	CcSEcCtD
Metyrapone—Skin disorder—Budesonide—ulcerative colitis	0.000609	0.00571	CcSEcCtD
Metyrapone—Dizziness—Nicotine—ulcerative colitis	0.000602	0.00565	CcSEcCtD
Metyrapone—Vomiting—Mercaptopurine—ulcerative colitis	0.000597	0.0056	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.00058	0.00544	CcSEcCtD
Metyrapone—Vomiting—Nicotine—ulcerative colitis	0.000579	0.00543	CcSEcCtD
Metyrapone—Headache—Nicotine—ulcerative colitis	0.00057	0.00535	CcSEcCtD
Metyrapone—Nausea—Mercaptopurine—ulcerative colitis	0.000558	0.00523	CcSEcCtD
Metyrapone—Skin disorder—Azathioprine—ulcerative colitis	0.000544	0.0051	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000541	0.00508	CcSEcCtD
Metyrapone—Nausea—Nicotine—ulcerative colitis	0.000541	0.00507	CcSEcCtD
Metyrapone—Hypertension—Mesalazine—ulcerative colitis	0.000539	0.00506	CcSEcCtD
Metyrapone—Pain—Budesonide—ulcerative colitis	0.000536	0.00503	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000528	0.00496	CcSEcCtD
Metyrapone—Hypotension—Azathioprine—ulcerative colitis	0.000523	0.00491	CcSEcCtD
Metyrapone—Gastrointestinal pain—Budesonide—ulcerative colitis	0.000513	0.00481	CcSEcCtD
Metyrapone—ABCC3—digestive system—ulcerative colitis	0.000508	0.0604	CbGeAlD
Metyrapone—Nervous system disorder—Mesalazine—ulcerative colitis	0.0005	0.00469	CcSEcCtD
Metyrapone—Abdominal pain—Budesonide—ulcerative colitis	0.000496	0.00465	CcSEcCtD
Metyrapone—Skin disorder—Mesalazine—ulcerative colitis	0.000495	0.00465	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000483	0.00453	CcSEcCtD
Metyrapone—Hypotension—Mesalazine—ulcerative colitis	0.000476	0.00447	CcSEcCtD
Metyrapone—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000458	0.00429	CcSEcCtD
Metyrapone—Abdominal pain—Azathioprine—ulcerative colitis	0.000442	0.00415	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.00044	0.00413	CcSEcCtD
Metyrapone—Pain—Mesalazine—ulcerative colitis	0.000436	0.00409	CcSEcCtD
Metyrapone—Angiopathy—Methylprednisolone—ulcerative colitis	0.000435	0.00408	CcSEcCtD
Metyrapone—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000417	0.00391	CcSEcCtD
Metyrapone—Dizziness—Budesonide—ulcerative colitis	0.000415	0.00389	CcSEcCtD
Metyrapone—CYP2A6—liver—ulcerative colitis	0.000404	0.0481	CbGeAlD
Metyrapone—Abdominal pain—Mesalazine—ulcerative colitis	0.000403	0.00378	CcSEcCtD
Metyrapone—Vomiting—Budesonide—ulcerative colitis	0.000399	0.00374	CcSEcCtD
Metyrapone—Angiopathy—Betamethasone—ulcerative colitis	0.000396	0.00371	CcSEcCtD
Metyrapone—Angiopathy—Dexamethasone—ulcerative colitis	0.000396	0.00371	CcSEcCtD
Metyrapone—Headache—Budesonide—ulcerative colitis	0.000393	0.00368	CcSEcCtD
Metyrapone—Hypertension—Prednisolone—ulcerative colitis	0.000393	0.00368	CcSEcCtD
Metyrapone—Alopecia—Dexamethasone—ulcerative colitis	0.000385	0.00361	CcSEcCtD
Metyrapone—Alopecia—Betamethasone—ulcerative colitis	0.000385	0.00361	CcSEcCtD
Metyrapone—Hypertension—Hydrocortisone—ulcerative colitis	0.000384	0.0036	CcSEcCtD
Metyrapone—ABCC3—liver—ulcerative colitis	0.000378	0.045	CbGeAlD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000376	0.00352	CcSEcCtD
Metyrapone—Nausea—Budesonide—ulcerative colitis	0.000372	0.00349	CcSEcCtD
Metyrapone—Dizziness—Azathioprine—ulcerative colitis	0.00037	0.00347	CcSEcCtD
Metyrapone—Hypertension—Triamcinolone—ulcerative colitis	0.000361	0.00339	CcSEcCtD
Metyrapone—Hypertension—Methylprednisolone—ulcerative colitis	0.00036	0.00338	CcSEcCtD
Metyrapone—Vomiting—Azathioprine—ulcerative colitis	0.000356	0.00334	CcSEcCtD
Metyrapone—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000356	0.00334	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000353	0.00331	CcSEcCtD
Metyrapone—Skin disorder—Hydrocortisone—ulcerative colitis	0.000352	0.0033	CcSEcCtD
Metyrapone—Headache—Azathioprine—ulcerative colitis	0.000351	0.00329	CcSEcCtD
Metyrapone—Angiopathy—Prednisone—ulcerative colitis	0.000344	0.00323	CcSEcCtD
Metyrapone—Hypotension—Hydrocortisone—ulcerative colitis	0.000339	0.00318	CcSEcCtD
Metyrapone—Dizziness—Mesalazine—ulcerative colitis	0.000337	0.00316	CcSEcCtD
Metyrapone—Alopecia—Prednisone—ulcerative colitis	0.000336	0.00315	CcSEcCtD
Metyrapone—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000334	0.00313	CcSEcCtD
Metyrapone—Nausea—Azathioprine—ulcerative colitis	0.000332	0.00312	CcSEcCtD
Metyrapone—Skin disorder—Methylprednisolone—ulcerative colitis	0.000331	0.0031	CcSEcCtD
Metyrapone—Hypertension—Betamethasone—ulcerative colitis	0.000328	0.00307	CcSEcCtD
Metyrapone—Hypertension—Dexamethasone—ulcerative colitis	0.000328	0.00307	CcSEcCtD
Metyrapone—Vomiting—Mesalazine—ulcerative colitis	0.000324	0.00304	CcSEcCtD
Metyrapone—Headache—Mesalazine—ulcerative colitis	0.000319	0.003	CcSEcCtD
Metyrapone—Hypotension—Methylprednisolone—ulcerative colitis	0.000318	0.00299	CcSEcCtD
Metyrapone—Pain—Prednisolone—ulcerative colitis	0.000317	0.00298	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000313	0.00294	CcSEcCtD
Metyrapone—Pain—Hydrocortisone—ulcerative colitis	0.00031	0.00291	CcSEcCtD
Metyrapone—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000304	0.00285	CcSEcCtD
Metyrapone—Nervous system disorder—Betamethasone—ulcerative colitis	0.000304	0.00285	CcSEcCtD
Metyrapone—Nausea—Mesalazine—ulcerative colitis	0.000303	0.00284	CcSEcCtD
Metyrapone—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000296	0.00278	CcSEcCtD
Metyrapone—Pain—Triamcinolone—ulcerative colitis	0.000292	0.00274	CcSEcCtD
Metyrapone—Hypotension—Dexamethasone—ulcerative colitis	0.000289	0.00272	CcSEcCtD
Metyrapone—Hypotension—Betamethasone—ulcerative colitis	0.000289	0.00272	CcSEcCtD
Metyrapone—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000287	0.00269	CcSEcCtD
Metyrapone—Hypertension—Prednisone—ulcerative colitis	0.000285	0.00268	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000279	0.00262	CcSEcCtD
Metyrapone—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000279	0.00261	CcSEcCtD
Metyrapone—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000269	0.00253	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000267	0.00251	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000267	0.00251	CcSEcCtD
Metyrapone—Pain—Dexamethasone—ulcerative colitis	0.000265	0.00248	CcSEcCtD
Metyrapone—Pain—Betamethasone—ulcerative colitis	0.000265	0.00248	CcSEcCtD
Metyrapone—Nervous system disorder—Prednisone—ulcerative colitis	0.000265	0.00248	CcSEcCtD
Metyrapone—Skin disorder—Prednisone—ulcerative colitis	0.000262	0.00246	CcSEcCtD
Metyrapone—CYP2E1—lymphoid tissue—ulcerative colitis	0.000259	0.0309	CbGeAlD
Metyrapone—CYP2E1—digestive system—ulcerative colitis	0.000256	0.0305	CbGeAlD
Metyrapone—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000253	0.00238	CcSEcCtD
Metyrapone—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000253	0.00238	CcSEcCtD
Metyrapone—Dizziness—Prednisolone—ulcerative colitis	0.000245	0.0023	CcSEcCtD
Metyrapone—Abdominal pain—Dexamethasone—ulcerative colitis	0.000245	0.0023	CcSEcCtD
Metyrapone—Abdominal pain—Betamethasone—ulcerative colitis	0.000245	0.0023	CcSEcCtD
Metyrapone—Dizziness—Hydrocortisone—ulcerative colitis	0.00024	0.00225	CcSEcCtD
Metyrapone—Headache—Prednisolone—ulcerative colitis	0.000233	0.00218	CcSEcCtD
Metyrapone—Vomiting—Hydrocortisone—ulcerative colitis	0.000231	0.00216	CcSEcCtD
Metyrapone—Headache—Hydrocortisone—ulcerative colitis	0.000227	0.00213	CcSEcCtD
Metyrapone—Dizziness—Triamcinolone—ulcerative colitis	0.000226	0.00212	CcSEcCtD
Metyrapone—Dizziness—Methylprednisolone—ulcerative colitis	0.000225	0.00211	CcSEcCtD
Metyrapone—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000221	0.00207	CcSEcCtD
Metyrapone—Nausea—Prednisolone—ulcerative colitis	0.000221	0.00207	CcSEcCtD
Metyrapone—Vomiting—Triamcinolone—ulcerative colitis	0.000217	0.00204	CcSEcCtD
Metyrapone—Vomiting—Methylprednisolone—ulcerative colitis	0.000217	0.00203	CcSEcCtD
Metyrapone—Nausea—Hydrocortisone—ulcerative colitis	0.000215	0.00202	CcSEcCtD
Metyrapone—Headache—Triamcinolone—ulcerative colitis	0.000214	0.00201	CcSEcCtD
Metyrapone—Headache—Methylprednisolone—ulcerative colitis	0.000213	0.002	CcSEcCtD
Metyrapone—Abdominal pain—Prednisone—ulcerative colitis	0.000213	0.002	CcSEcCtD
Metyrapone—CYP3A4—digestive system—ulcerative colitis	0.000206	0.0245	CbGeAlD
Metyrapone—Dizziness—Dexamethasone—ulcerative colitis	0.000205	0.00192	CcSEcCtD
Metyrapone—Dizziness—Betamethasone—ulcerative colitis	0.000205	0.00192	CcSEcCtD
Metyrapone—Nausea—Triamcinolone—ulcerative colitis	0.000203	0.0019	CcSEcCtD
Metyrapone—Nausea—Methylprednisolone—ulcerative colitis	0.000202	0.0019	CcSEcCtD
Metyrapone—Vomiting—Dexamethasone—ulcerative colitis	0.000197	0.00185	CcSEcCtD
Metyrapone—Vomiting—Betamethasone—ulcerative colitis	0.000197	0.00185	CcSEcCtD
Metyrapone—Headache—Dexamethasone—ulcerative colitis	0.000194	0.00182	CcSEcCtD
Metyrapone—Headache—Betamethasone—ulcerative colitis	0.000194	0.00182	CcSEcCtD
Metyrapone—CYP2E1—liver—ulcerative colitis	0.000191	0.0227	CbGeAlD
Metyrapone—Nausea—Betamethasone—ulcerative colitis	0.000184	0.00173	CcSEcCtD
Metyrapone—Nausea—Dexamethasone—ulcerative colitis	0.000184	0.00173	CcSEcCtD
Metyrapone—Dizziness—Prednisone—ulcerative colitis	0.000178	0.00167	CcSEcCtD
Metyrapone—Vomiting—Prednisone—ulcerative colitis	0.000172	0.00161	CcSEcCtD
Metyrapone—Headache—Prednisone—ulcerative colitis	0.000169	0.00159	CcSEcCtD
Metyrapone—Nausea—Prednisone—ulcerative colitis	0.00016	0.0015	CcSEcCtD
Metyrapone—CYP3A4—liver—ulcerative colitis	0.000153	0.0183	CbGeAlD
